Nakagawa Y

ORCID: 0000-0003-4103-2423 · 2 papers in corpus

2024

Phase I study of the safety and clinical activity of the interleukin-8 inhibitor AMY109 combined with atezolizumab in patients with advanced solid cancers.

Journal for immunotherapy of cancer ·doi:10.1136/jitc-2024-009262

BackgroundImmunosuppressive conditions within the tumor microenvironment (TME) can allow tumors to evade the immune system, including by hampering programmed death ligand 1 (PD-L1) inhibitor activity. Interleukin (IL)-8 contributes to immun…

2018

Lack of a meaningful association between dietary patterns and in vitro fertilization outcome among Japanese women.

Reproductive medicine and biology ·doi:10.1002/rmb2.12223

PurposeThe purpose of this study was to examine whether preconception maternal dietary pattern is associated with in vitro fertilization (IVF) outcome among Japanese women.MethodsThis prospective study included 140 Japanese women who underw…